Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 11/20 | 0.80 |
| ▸ | PDPK1 | O15530 | 3/20 | 0.80 |
| ▸ | PHLPP1 | O60346 | 3/20 | 0.80 |
| ▸ | ILK | Q13418 | 3/20 | 0.80 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.59 |
| ▸ | TTPA | P49638 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma-Tocopherol SCHEMBL14695405 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL8408124 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL29373100 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL16430717 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL29620131 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| SCHEMBL15441242 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL14580952 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL39640 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL17874900 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA | |
| Gamma-Tocopherol SCHEMBL120346 | 0.94 | AKT1 (0.91) | AKT1PDPK1PHLPP1ILKLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220257533-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | PTC THERAPEUTICS INC (US) | 2022-08-18 | — | — | US | claimed |
| US-20190029975-A1 | TOCOPHEROL AND TOCOTRIENOL QUINONE DERIVATIVES FOR INCREASING THIOSULFATE LEVELS OR DECREASING HYDROGEN SULFIDE LEVELS | BIOELECTRON TECHNOLOGY CORPORATION | 2019-01-31 | — | — | US | claimed |
| US-20180333389-A1 | VITAMIN E COMPOSITIONS AND METHODS OF USE THEREFOR | BIOELECTRON TECH CORP (US) | 2018-11-22 | — | — | US | claimed |
| EP-3402472-A1 | TOCOPHEROL AND TOCOTRIENOL QUINONE DERIVATIVES FOR INCREASING THIOSULFATE LEVELS OR DECREASING HYDROGEN SULFIDE LEVELS | BioElectron Technology Corporation (US) | 2018-11-21 | — | — | EP | claimed |
| WO-2018191732-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | BIOELECTRON TECHNOLOGY CORPORATION (US) | 2018-10-18 | — | — | WO | claimed |
| WO-2017123822-A1 | TOCOPHEROL AND TOCOTRIENOL QUINONE DERIVATIVES FOR INCREASING THIOSULFATE LEVELS OR DECREASING HYDROGEN SULFIDE LEVELS | BIOELECTRON TECHNOLOGY CORPORATION (US) | 2017-07-20 | — | — | WO | claimed |
| WO-2016114860-A1 | QUINONES FOR PROTECTION AGAINST RADIATION EXPOSURE | EDISON PHARMACEUTICALS, INC. (US) | 2016-07-21 | — | — | WO | claimed |
| US-20150216820-A1 | QUINONE DERIVATIVES FOR USE IN THE MODULATION OF REDOX STATUS OF INDIVIDUALS | BIOELECTRON TECHNOLOGY CORPORATION | 2015-08-06 | — | — | US | claimed |
| EP-2892516-A1 | QUINONE DERIVATIVES FOR USE IN THE MODULATION OF REDOX STATUS OF INDIVIDUALS | Edison Pharmaceuticals, Inc. (US) | 2015-07-15 | — | — | EP | claimed |
| WO-2014039862-A1 | QUINONE DERIVATIVES FOR USE IN THE MODULATION OF REDOX STATUS OF INDIVIDUALS | EDISON PHARMACEUTICALS, INC. (US) | 2014-03-13 | — | — | WO | claimed |
| WO-2011113018-A1 | MEASUREMENT AND CONTROL OF BIOLOGICAL TIME | AMPERE LIFE SCIENCES, INC. (US) | 2011-09-15 | — | — | WO | claimed |
| US-20220257533-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | PTC THERAPEUTICS INC (US) | 2022-08-18 | — | — | US | disclosed |
| US-20210322337-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | PTC THERAPEUTICS, INC. | 2021-10-21 | — | — | US | disclosed |
| US-20200121618-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | EDISON PHARMACEUTICALS, INC. | 2020-04-23 | — | — | US | disclosed |
| US-20190029975-A1 | TOCOPHEROL AND TOCOTRIENOL QUINONE DERIVATIVES FOR INCREASING THIOSULFATE LEVELS OR DECREASING HYDROGEN SULFIDE LEVELS | BIOELECTRON TECHNOLOGY CORPORATION | 2019-01-31 | — | — | US | disclosed |
| EP-2362726-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | Edison Pharmaceuticals, Inc. (US) | 2011-09-07 | — | — | EP | disclosed |
| US-20110046156-A1 | TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS | EDISON PHARMACEUTICALS, INC. | 2011-02-24 | — | — | US | disclosed |
| EP-2262519-A2 | TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS | Edison Pharmaceuticals, Inc. (US) | 2010-12-22 | — | — | EP | disclosed |
| WO-2010045220-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | EDISON PHARMACEUTICALS, INC. (US) | 2010-04-22 | — | — | WO | disclosed |
| WO-2009111543-A2 | TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS | EDISON PHARMACEUTICALS, INC. (US) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200121618-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | MPO, GPX4, GPX1 | AKT1 2692/4885PDPK1 2718/4885PHLPP1 3557/4885 |
| US-20220257533-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND OXIDATIVE STRESS | MPO, GPX4, GPX1 | AKT1 2692/4885PDPK1 2718/4885PHLPP1 3557/4885 |
| US-20110046156-A1 | TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS | TXN2, TXNRD2, OTC | AKT1 2965/4885PDPK1 3374/4885PHLPP1 2765/4885 |
| US-20180333389-A1 | VITAMIN E COMPOSITIONS AND METHODS OF USE THEREFOR | CYP27B1, TTPA, ECH1 | AKT1 1435/4885PDPK1 1721/4885PHLPP1 2122/4885 |
| US-20210322337-A1 | TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS | GPX4, TXN2, TXNRD1 | AKT1 2101/4885PDPK1 3034/4885PHLPP1 4230/4885 |
| US-20150216820-A1 | QUINONE DERIVATIVES FOR USE IN THE MODULATION OF REDOX STATUS OF INDIVIDUALS | GSR, GLS, GPX4 | AKT1 3219/4885PDPK1 1457/4885PHLPP1 3716/4885 |
| US-20190029975-A1 | TOCOPHEROL AND TOCOTRIENOL QUINONE DERIVATIVES FOR INCREASING THIOSULFATE LEVELS OR DECREASING HYDROGEN SULFIDE LEVELS | SQOR, TST, TXNRD3 | AKT1 4146/4885PDPK1 3123/4885PHLPP1 3565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.